Clinical use of ACQUIRE Therapy for Children Diagnosed With CASK-Gene Related Disabilities.
Dory A Wallace, Mary Rebekah Trucks, Stephanie C DeLuca
https://pubmed.ncbi.nlm.nih.gov/39610761/Actively Recruiting
Led by Virginia Polytechnic Institute and State University · Updated on 2026-01-21
500
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating intensive therapeutic services for children with motor impairments caused by neuromotor disorders, including cerebral palsy, microcephaly, autism, brain trauma, acquired brain injury, and pediatric stroke. The study focuses on ACQUIREc Therapy, a form of pediatric constraint-induced movement therapy that aims to improve asymmetric motor abilities between the two sides of the body. This therapy involves constraining the less impaired upper limb and providing high-dose therapy to the more impaired side, with therapy lasting many hours per day over several weeks. The treatment involves ACQUIRE Therapy, which combines intensive therapy services with behavioral shaping techniques delivered by trained occupational or physical therapists. Children receive play-based therapy designed to help them acquire new motor skills in their weaker limbs. Therapy is delivered in natural environments and includes sessions lasting up to 6 hours per day, 5 days a week, for 2 to 4 weeks. The study also collects clinical data from children receiving these therapies at the FBRI VTC Neuromotor Research Clinic. Participants undergo various assessments including the Emerging Behaviors Scale measured up to 12 months, and motor function tests like the Assisting Hand Assessment, Pediatric Motor Activity Log, Peabody Developmental Motor Scales 2, and Bayley Motor Scales of Infant Development -III before and after treatment. Participation is voluntary, and children continue to receive clinical care regardless of study involvement. The research team monitors motor skill improvements and other outcomes over time as part of this observational study.
CONDITIONS
The FBRI VTC Neuromotor Research Clinic
S
Stephanie DeLuca, PhD
L
Laura Bateman
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Virginia Polytechnic Institute and State University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Duration not specified
Participants receive intensive therapy services combined with operant conditioning delivered by trained occupational or physical therapists.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Dory A Wallace, Mary Rebekah Trucks, Stephanie C DeLuca
https://pubmed.ncbi.nlm.nih.gov/39610761/Stephanie C DeLuca, Dory A Wallace, Mary Rebekah Trucks...
https://pubmed.ncbi.nlm.nih.gov/29258560/Virginia Polytechnic Institute and State University
Lead Sponsor